Part I. Synthesis, biological evaluation and docking studies of new 2-furylbenzimidazoles as antiangiogenic agents

New synthesized 2-furylbenzimidazoles inhibited VEGF in tested samples with % inhibition = 86-98% and showed cytotoxic activity against MCF-7 cancer cell line with (IC50: 6.98-22.40 μg/ml).